Skip to main content
. Author manuscript; available in PMC: 2016 Jan 1.
Published in final edited form as: Hepatology. 2014 Aug 25;61(1):98–107. doi: 10.1002/hep.27235

Table 3.

Comparison of changes in immunohistochemical data with and without adjusting for baseline values: Placebo vs. Vitamin E groups.

Changes in: Placebo (N=29) Vitamin E (N=30) p-value# β±SE/ OR[95%CI] p-value
Shh+ hepatocytes, cells/HPF 1.2±10.7 −3.0±8.3 0.048 −4.4±2.1 0.037
K8/18 negative cells or ubiquitin-positive foci/HPF 0.2±1.4 −2.9±1.3 0.082 −2.6±1.2 0.037
α-SMA+ stain score, 0 to 4 0 (0, 0) 0 (−1, 0) 0.097 1.8[0.6, 5.6] 0.34
Gli2/sox9+ stain score, 0 to 4 0 (0, 0) 0 (−1, 0) 0.068 1.7[0.5, 5.5] 0.36

Data were presented as mean ± SD for numeric variables and median (IQR) for ordinal variables. #: Wilcoxon Rank-Sum tests There were some cases with missing data: Shh-positive hepatocytes (N=2), K8/18 negative or ubiquitin-positive foci (N=14), α-SMA-positive stain score (N=1) and gli2/sox9-positive stain score (N=2). B-coefficients and SE were computed in multiple linear regression models, while cumulative odds ratios were computed in multiple ordinal logistic regression models, both of which were adjusted for baseline values.

HHS Vulnerability Disclosure